LOUISVILLE, KY — ScionHealth announced today they will begin purchasing certain bulk drugs from Mark Cuban’s Cost Plus Drug Company (“Cost Plus Drugs”) and delivered to Safecor Health’s SafecorLogics program. The integrated approach, combining the expertise of three organizations, will enable ScionHealth to deliver exceptional value to patients while ensuring the sustainability of its healthcare delivery model.
Cost Plus Drugs was launched in January 2022 with the mission of providing cheaper pharmaceuticals by eliminating middlemen and offering a transparent pricing model. The company’s Cost Plus Drugs Marketplace launched in 2023 to bring this same philosophy to healthcare business purchasers. “Everyone should be able to access their prescriptions at affordable and transparent prices,” said Dr. Alexander Oshmyansky, CEO at Cost Plus Drugs. “We are thrilled to work with ScionHealth as one of our initial health system partnerships and look forward to our work together with their team and Safecor Health.”
Since September of 2023, ScionHealth has worked with Safecor Health as a strategic supply chain partner through Safecor Health’s SafecorLogics program. SafecorLogics was developed to help healthcare systems centralize their own unit-dose supply chains, giving them greater cost savings and mitigating waste while optimizing staffing and operations. ScionHealth expanded its utilization of the program in January of 2024.
“Across the industry and particularly in hospital settings, we are facing the challenges of rising drug and supply costs and navigating staffing shortages,” said Rob Jay, ScionHealth’s Chief Executive Officer. “ScionHealth is continually looking for innovative approaches to address these issues while advancing the delivery of high-quality, patient-centered care and well-being to our communities. SafecorLogics has already been an effective solution to help us address these challenges. Now, by introducing Cost Plus Drugs, we are confident we’ll see even more success managing drug costs and enhancing care delivery across the ScionHealth network.”
Steve Fischbach, Safecor Health’s Chief Executive Officer, echoed this sentiment, saying “We are proud to partner with innovative companies like ScionHealth and we are excited to expand that partnership with products from Cost Plus Drugs. It’s a great fit for the SafecorLogics program and we’re sure it will lead to meaningful savings for ScionHealth.”
The drugs ScionHealth purchases in bulk from Cost Plus Drugs will be delivered to Safecor Health's unit-dose packaging centers where they will be packaged, stored, and shipped same-day as requested by ScionHealth's locations.
